These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6333809)

  • 1. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
    Keren G; Tepper D; Butler B; Torres V; Somberg JC
    Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolongation of QT interval and antiarrhythmic action of bepridil.
    Somberg J; Torres V; Flowers D; Miura D; Butler B; Gottlieb S
    Am Heart J; 1985 Jan; 109(1):19-27. PubMed ID: 3871296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and antiarrhythmic properties of bepridil.
    Prystowsky EN
    Am J Cardiol; 1985 Mar; 55(7):59C-62C. PubMed ID: 3872056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of cibenzoline in preventing PES induction of ventricular tachycardia in the dog.
    Keren G; Tepper D; Butler B; Miura D; Aogaichi K; Somberg J
    J Clin Pharmacol; 1984 Oct; 24(10):466-72. PubMed ID: 6511989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic and antiarrhythmic actions of bepridil. Comparison with verapamil and ajmaline for atrioventricular reentrant tachycardia.
    Rowland E; McKenna WJ; Krikler DM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1513-9. PubMed ID: 3873867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
    Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bepridil for recurrent sustained ventricular tachycardias: assessment using electrophysiologic testing.
    Levy S; Cointe R; Metge M; Faugere G; Valeix B; Gerard R
    Am J Cardiol; 1984 Sep; 54(6):579-81. PubMed ID: 6332516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic effects of bepridil in patients with refractory ventricular tachycardia assessed by programmed electrical stimulation.
    Schmitt C; Brachmann J; Hölzel C; Waldecker B; Schöls W; Beyer T; Kübler W
    Clin Cardiol; 1990 Dec; 13(12):864-8. PubMed ID: 2282730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
    Brachmann J; Aidonidis I; Dembowsky K; Seller H; Kuebler W
    Cardiology; 1989; 76(3):211-21. PubMed ID: 2789099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers that prolong the QT interval.
    Somberg JC
    Am Heart J; 1985 Feb; 109(2):416-21. PubMed ID: 3871300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral and intravenous bepridil in the treatment of recurrent sustained ventricular tachycardias. Electropharmacological study].
    Lévy S; Metge M; Cointe R; Labrunie P; Valeix P; Gérard R
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():63-6. PubMed ID: 3938261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of intravenous LNC-834, a new antiarrhythmic agent, and quinidine in canine models of arrhythmia.
    D'Alonzo AJ; Butterfield JL; Drexler AP; Sergio SL
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):506-17. PubMed ID: 1700225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hirosawa K
    Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bepridil, diltiazem and verapamil on atrial refractoriness and heart rate in the conscious dog: comparison with quinidine.
    Boucher M; Dubray C; Duchêne-Marullaz P
    Gen Pharmacol; 1991; 22(4):581-7. PubMed ID: 1936892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD; Newman D; Ham M; Dorian P
    J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromechanical effects of bepridil on rabbit isolated hearts.
    Anno T; Furuta T; Itoh M; Kodama I; Toyama J; Yamada K
    Br J Pharmacol; 1984 Jan; 81(1):41-7. PubMed ID: 6608388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of ventricular refractoriness by class Ia antiarrhythmic drugs in the prevention of ventricular tachycardia induction.
    Kus T; Costi P; Dubuc M; Shenasa M
    Am Heart J; 1990 Oct; 120(4):855-63. PubMed ID: 2220538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol.
    Buxton AE; Waxman HL; Marchlinski FE; Josephson ME
    Am J Cardiol; 1984 Mar; 53(6):738-44. PubMed ID: 6702622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and electrophysiologic effects of MDL 11,939, a novel class III antiarrhythmic agent in anesthetized dogs.
    Koerner JE; Dage RC
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):383-93. PubMed ID: 1700208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.